OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...

Wondering whether Recursion Pharmaceuticals at around US$3.39 is a bargain or a value trap? This article focuses squarely on what the current share price might be telling you about the business. The ...

Recursive Superintelligence raises $500M to accelerate AI innovation, signaling strong investor confidence in next-gen ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to supercharge its AI-driven drug discovery platform through an expanded ...

Penn researchers have developed a smarter AI method for solving notoriously difficult inverse equations, which help ...

Penn Engineers have developed a new way to use AI to solve inverse partial differential equations (PDEs), a particularly ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Enterprise AI systems can be corrupted through data poisoned by accident, adversaries, or bad hygiene. Most organizations ...

Anthropic’s co-founder Jack Clark has made a bold prediction that AI systems may be capable of rebuilding themselves from ...